Linked Life Data

21382773

Source:http://linkedlifedata.com/resource/pubmed/id/21382773

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2011-4-4
pubmed:abstractText
BACKGROUND AND METHODOLOGY: The paediatric rare tumours group from the Société française des cancers de l'enfant makes syntheses and guidelines for diagnosis and treatment for localized paediatric inflammatory myofibroblastic tumours according to international articles. MAIN UPDATING: All ages are concerning. Localizations are ubiquitous, more frequently in the superior and inferior airway. Histology showed a majority of fusiform cells, corresponding to myofibroblastic cells and an inflammatory infiltrate. Inflammatory myofibroblastic tumour diagnosis should only be confirmed in the absence of sarcoma molecular markers. CONCLUSIONS: Distinction between inflammatory myofibroblastic tumour and sarcoma is essential due to the different care. The curative treatment of inflammatory myofibroblastic tumour consists on surgery with before or after corticotherapy. In case of unresectability, chemotherapy may be helpful to avoid mutilating surgery.
pubmed:language
fre
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1769-6917
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
98
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
209-16
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
[Guidelines for management of localized inflammatory myofibroblastic tumours in children].
pubmed:affiliation
CHU Charles-Nicolle, service d'immuno-hémato-oncologie pédiatrique, Rouen, France. aude.marie-cardine@chu-rouen.fr
pubmed:publicationType
Journal Article, English Abstract, Practice Guideline